Old Players with a Newly Defined Function: Fra-1 and c-Fos Support Growth of Human Malignant Breast Tumors by Activating Membrane Biogenesis at the Cytoplasm

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Motrich, Ruben D ^a   Castro, Gonzalo M ^a,b   Caputto, Beatriz L ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PHOSPHOLIPID; PROTEIN C FOS; TRANSCRIPTION FACTOR FRA 1;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER CONTROL; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRAIN MDA MB231; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTRADUCTAL CARCINOMA; MEMBRANE FORMATION; PHOSPHOLIPID SYNTHESIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; PHOSPHOLIPIDS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 84871798095     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053211     Document Type: Article

References (49)

1. Angel P, Karin M, (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157.
2. Morgan J, Curran T, (1995) Immediate early gene expression: ten years on. Trends Neurosci 18: 66-67.
3. Caputto BL, Guido ME, (2000) Immediate early gene expression within the visual system: light and circadian regulation in the retina and the suprachiasmatic nucleus. Neurochem Res 25: 153-162.
4. Kouzarides T, Ziff E, (1989) Leucine zippers of Fos, Jun and GCN4 dictate dimerization specificity and thereby control DNA binding. Nature 340: 568-571.
5. Shaulian E, Karin M, (2002) AP-1 as regulator of cell life and death. Nat Cell Biol 4: 131-136.
6. Guido ME, de Arriba Zerpa GA, Bussolino DF, Caputto BL, (1996) The immediate early gene c-fos regulates the synthesis of phospholipids but not of gangliosides. J Neurosci Res 43: 93-98.
7. Bussolino DF, de Arriba Zerpa GA, Grabois VR, Conde CB, Guido ME, et al. (1998) Light affects c-fos expression and phospholipid synthesis in both retinal ganglion cells and photoreceptor cells in an opposite way for each cell type. Mol Brain Res 58: 10-15.
8. De Arriba Zerpa GA, Guido ME, Bussolino DF, Pasquare SJ, Castagnet PI, et al. (1999) Light exposure activates retina ganglion cell lysophosphatidic acid acyl transferase and phosphatidic acid phosphatase by a c-fos-dependent mechanism. J Neurochem 73: 1228-1235.
9. Garbarino-Pico E, Valdez DJ, Contín MA, Pasquaré SJ, Castagnet PI, et al. (2005) Rhythms of glycerophospholipid synthesis in retinal inner nuclear layer cells. Neurochem Int 47: 260-270.
10. Bussolino DF, Guido ME, Gil GA, Borioli GA, Renner ML, et al. (2001) c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism. FASEB J 15: 556-558.
11. Gil GA, Bussolino DF, Portal MM, Alfonso Pecchio A, Renner ML, et al. (2004) c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells. Mol Biol Cell 15: 1881-1894.
12. Crespo PM, Silvestre DC, Gil GA, Maccioni HJ, Daniotti JL, et al. (2008) c-Fos activates glucosylceramide synthase and glycolipid synthesis in PC12 cells. J Biol Chem 283: 31163-31671.
13. Portal MM, Ferrero GO, Caputto BL, (2007) N-Terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation. Oncogene 26: 3551-3558.
14. Ferrero GO, Velazquez FN, Caputto BL, (2011) The kinase c-Src and the phosphatase TC45 coordinately regulate c-Fos tyrosine phosphorylation and c-Fos phospholipid synthesis activation capacity. Oncogene 31: 3381-3391.
15. Silvestre DC, Gil GA, Tomasini N, Bussolino DF, Caputto BL, (2010) Growth of peripheral and central nervous system tumors is supported by cytoplasmic c-Fos in humans and mice. PLoS One 5: e9544.
16. Gil GA, Silvestre DC, Tomasini N, Bussolino DF, Caputto BL, (2012) Controlling Cytoplasmic c-Fos Controls Tumour Growth in the Peripheral and Central Nervous System. Neurochem Res 37: 1364-1371.
17. Alfonso Pecchio A, Cardozo Gizzi AM, Renner ML, Molina-Calavita M, Caputto BL, (2011) c-Fos activates and physically interacts with specific enzymes of the pathway of synthesis of polyphosphoinositides. Mol Biol Cell 22: 4716-4725.
18. Cohen DR, Curran T, (1988) fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol Biol Cell 8: 2063-2069.
19. Rauscher FJ 3rd, Cohen DR, Curran T, Bos TJ, Vogt PK, et al (1988) Fos-associated protein p39 is the product of the jun proto-oncogene. Science 240: 1010-1016.
20. Young MR, Nair R, Bucheimer N, Tulsian P, Brown N, et al. (2002) Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol Cell Biol 22: 587-598.
21. Casalino L, De Cesare D, Verde P, (2003) Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol 23: 4401-4415.
22. Young MR, Colburn NH, (2006) Fra-1 a target for cancer prevention or intervention. Gene 379: 1-11.
23. Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, et al. (1999) cJun overexpression in MCF7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18: 6063-6070.
24. Basbous J, Chalbos D, Hipskind R, Jariel-Encontre I, Piechaczyk M, (2007) Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol 27: 3936-3950.
25. Suzuki T, Okuno H, Yoshida T, Endo T, Nishina H, et al. (1991) Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res 19: 5537-5542.
26. Yoshioka K, Deng T, Cavigelli M, Karin M, (1995) Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc Natl Acad Sci USA 92: 4972-4976.
27. Milde-Langosch K, (2005) The Fos family of transcription factors and their role in tumorigenesis. Eur J Cancer 41: 2449-2461.
28. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, et al. (2001) Identification of gene expression profiles that predict the aggressive behaviour of breast cancer cells. Cancer Res 61: 5168-5178.
29. Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, et al. (1998) Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 18: 7095-7105.
30. Belguise K, Kersual N, Galtier F, Chalbos D, (2005) FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24: 1434-1444.
31. Song Y, Song S, Zhang D, Zhang Y, Chen L, et al. (2006) An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy. BMC Cancer 6; 298-304.
32. Nakajima H, Mizuta N, Sakaguchi K, Fujiwara I, Mizuta M, et al. (2007) Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity. J Antibiot (Tokyo) 60: 682-689.
33. Chiappetta G, Ferraro A, Botti G, Monaco M, Pasquinelli R, et al. (2007) FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer 7: 17-27.
34. Logullo AF, Stiepcich MM, Osório CA, Nonogaki S, Pasini FS, et al. (2011) Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma. Histopathology 58: 617-625.
35. Ramos-Nino ME, Blumen SR, Pass H, Mossman BT, (2007) Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas. Mol Cancer 6: 81-95.
36. Usui A, Hoshino I, Akutsu Y, Sakata H, Nishimori T, et al. (2012) The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma. Cancer 118: 3387-3396.
37. Debinski W, Gibo D, (2005) Fos-related antigen 1 modulates malignant features of glioma cells. Mol Cancer Res 3: 237-249.
38. Chiappetta G, Tallini G, De Biasio MC, Pentimalli F, de Nigris F, et al. (2000) FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res 6: 4300-4306.
39. Fleischmann A, Hafezi F, Elliott C, Remé CE, Rüther U, et al. (2000) Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev 14; 2695-2700.
40. Borioli GA, Caputto BL, Maggio B, (2001) c-Fos is surface active and interacts differentially with phospholipid monolayers. Biochem Biophys Res Commun 280: 9-13.
41. Gaggiotti MC, Del Boca M, Castro G, Caputto BL, Borioli GA, (2009) The immediate-early oncoproteins Fra-1, c-Fos, and c-Jun have distinguishable surface behavior and interactions with phospholipids. Biopolymers 91: 710-718.
42. Torgerson TR, Colosia AD, Donahue JP, Lin YZ, Hawiger J, (1998) Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. J Immunol 161: 6084-6092.
43. Debinski W, Gibo DM, (2011) Fos-related antigen 1 (Fra-1) pairing with and transactivation of JunB in GBM cells. Cancer Biol Ther 11: 254-262.
44. Ma K, Chang D, Gong M, Ding F, Luo A, et al. (2009) Expression and significance of FRA-1 in Non-Small-Cell lung cancer. Cancer Inv 27: 353-359.
45. Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, et al. (1998) Fra-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endo 12: 973-985.
46. Leppä S, Eriksson M, Saffrich R, Ansorge W, Bohmann D, (2001) Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Mol Cell Biol 21: 4369-4378.
47. Chipuk JE, Maurer U, Green DR, Schuler M, (2003) Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4: 371-381.
48. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, et al. (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-252.
49. Green DR, Kroemer G, (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130.